Pharmacokinetics of penciclovir after oral administration of its prodrug famciclovir to horses.

The research article explores the reaction of horses to the oral intake of the drug famciclovir, which is converted into its active form, penciclovir, in the body. It delves into the time it takes to reach maximum plasma concentrations and its elimination phase duration.

Research Process

• The research focused on studying the pharmacokinetics of penciclovir, a drug used against the herpes virus, in horses after they are orally administered its prodrug, famciclovir.
• Famciclovir was given orally to the horses at the dose of 20mg/kg.
• The maximum plasma concentrations of penciclovir were then observed to occur between 0.75 and 1.5 hr after dosing.
• The range of the maximum plasma concentrations of penciclovir was between 2.22 and 3.56 microg/ml.

Findings

• The study found that the concentration of penciclovir declined in a biphasic manner after peaking.
• The study noticed a rapid elimination phase with a mean half-life of approximately 1.73 hours. This is the period in which the concentration of the drug decreased rapidly in plasma.
• Following the rapid elimination phase, there was a slow elimination phase which had a mean half-life of approximately 34.34 hours. Here, the concentration of the drug decreased in plasma at a slower pace.
• The pharmacokinetic profiles, the body’s effect on the drug in terms of absorption, distribution, metabolism, and excretion, which were observed in this study, were matched with the profiles of valacyclovir-acyclovir anti-herpes virus drug treatment in horses that was previously reported.

Implications

• The findings imply that the prodrug famciclovir is converted into the active drug penciclovir upon oral administration and absorption.
• The established behavior of the absorption and elimination of penciclovir could be instrumental in determining the appropriate dosage and frequency for horses to effectively alleviate herpes virus symptoms.